About the Authors

Al Shaimaa Hasan

Affiliations Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, Department of Medical Pharmacology, Qena Faculty of Medicine, South Valley University, Qena, Egypt

Lan Luo

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Chen Yan

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Tian-Xia Zhang

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Yoshishige Urata

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Shinji Goto

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Safwat A. Mangoura

Affiliation Department of Medical Pharmacology, Qena Faculty of Medicine, South Valley University, Qena, Egypt

Mahmoud H. Abdel-Raheem

Affiliation Department of Medical Pharmacology, Qena Faculty of Medicine, South Valley University, Qena, Egypt

Shouhua Zhang

Affiliation Department of General Surgery, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China

Tao-Sheng Li

litaoshe@nagasaki-u.ac.jp

Affiliation Department of Stem Cell Biology, Atomic Bomb Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan

Competing Interests

The authors declare no competing financial interests.

Author Contributions

Conceptualization: AH MAR SZ TL. Data curation: AH TL. Formal analysis: AH LL CY TZ YU SG MAR SM SZ TL. Funding acquisition: AH TL. Investigation: AH LL CY TZ YU SG MAR SM SZ TL. Methodology: AH MAR SZ TL. Project administration: TL. Resources: AH LL CY TZ YU SG SZ TL. Software: LL CY YU SG. Supervision: TL. Validation: MAR SZ TL. Visualization: AH LL CY TZ YU SG MAR SM SZ TL. Writing – original draft: AH TL. Writing – review & editing: AH TL.